Genetic and hypoxic alterations of the microRNA‐210‐ISCU1/2 axis promote iron–sulfur deficiency and pulmonary hypertension

Kevin P. White(University of Chicago), Stephen Y. Chan(University of Pittsburgh Medical Center), William D. Wallace(University of California, Los Angeles), Omar F. Khan(University of Toronto), Sara O. Vargas(Harvard University Press), Majed Matar(Celsion (United States)), Aaron B. Waxman(Brigham and Women's Hospital), Craig Hemann(The Ohio State University), Rahul Kumar(San Francisco General Hospital), Laurence A. Bindoff(Haukeland University Hospital), Iván O. Rosas(Brigham and Women's Hospital), Bernadette R. Gochuico(National Human Genome Research Institute), Daniel G. Anderson(Massachusetts Institute of Technology), James E. Dahlman(Georgia Institute of Technology), Rajeev Saggar(University of Arizona), Andrew Hale(Brigham and Women's Hospital), Jay L. Zweíer(The Ohio State University), Mark A. Perrella(Brigham and Women's Hospital), Rajan Saggar(Los Angeles Medical Center), Juan C. Osorio(Laboratory of Molecular Genetics), Haydn M. Prosser(Wellcome Sanger Institute), Kevin J. Polach(Celsion (United States)), Richard C. Jin(Mission Heritage Medical Group), Alexander R. Opotowsky(Cincinnati Children's Hospital Medical Center), Kathleen J. Haley(Boston University), Yu Lu(Brigham and Women's Hospital), B. Nelson Chau(Unknown), David Systrom(Harvard University), Andrew Bader(Harvard–MIT Division of Health Sciences and Technology), Nicolai Maroni Johannessen(University of Bergen), Robert Langer(Massachusetts Institute of Technology), David J. Ross(Natera (United States)), Sofia Annis(Brigham and Women's Hospital), Brian B. Graham(San Francisco General Hospital)
EMBO Molecular Medicine
March 30, 2015
Cited by 133


Related Papers